Technical Strength Analyser Available at Technical Analysis of Stocks    Interactive Charts Enhanced to include Financial & Technical Data in One View
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Stock Analysis of Sun Pharma Advanced Resea, Birds-Eye-view On Returns/Technicals/Funda/F&O

About Strength Screener

Charts Of Sun Pharma Advanced Resea

1D   1W   2W   1M   3M   1Y   2Y   5Y   
Interactive Charts

Price / Volume Action

CodeSPARC
EOD Share Price198.25
Previous Share Price185.85
Price Change 12.40
Change % 6.67%
Volume2277.86 K
Five Day Avg Vol785.86 K
Beta1.00197
Last Business Date27-Jan-20

Price Gain/Loss

DurationAbsolute ChgChg %
One Week 4.95 2.56
Two Weeks 12.30 6.61
One Month 42.30 27.12
Three Months 69.80 54.34
Six Months 33.20 20.12
One Year 30.30 18.04

Highs / Lows

DurationHighLow
One Week201.25181.2
Two Weeks201.25181.2
One Month201.25155.2
Three Months201.25126.4
Six Months201.25113.4
One Year203.9112.3

Key Moving Average

MA SMAEMA
5 Days 187.49189.944
15 Days 184.323183.559
20 Days 178.145180.66
50 Days 167.922169.264
100 Days 154.52161.618
200 Days 152.183169.455
Detailed MA Analysis of SPARC ...

Key Technical Indicators

MACD 7.79
RSI 75.75
RSI (Smooth) 69.37
ADX 40.28
Chaikin Money Flow 0.160
Williams %R -7.673
PSAR 181.20
Detailed Tech Analysis SPARC ...

Financial Data Highlights

Market Cap5227.44
Book Value/ Share5.315
Enterprise Value-6110.468
Revenue TTM139.22
Gross Profit TTM165.54
Revenue /Share TTM5.38
Consensus Target525.00
Key Financial Highlights SPARC ...

Financial Ratios of SPARC

EPS-6.776
PE0.000
Div/Share0.000
Div Yield0.000
Trailing PE0.000
Forward PE0.000
Price/Book37.30
Key Financial Ratios of SPARC ...

Key Profit & Loss Data

Period31_Mar_2019Growth
Net Inc -145.431 26.18 %
Ops Income-152.118 39.34 %
Revenue182.87 133.67 %
Ops Expense334.99 1.81 %
PBT-145.431 26.18 %
Gross Profit165.54 247.92 %
Div Paid0 � %
Key P&L SPARC ...

Price Range (PR) /Volatility

PeriodAvg PR Range %
LBD PR17.658.90
Week PR17.658.90
Month PR46.0523.23
5 Day Period8.764.80
10 Day Period7.624.13
5 Week Period17.3110.44
3 Months Period31.9020.79
Price Range /Volatility SPARC ...

Highlights & Chart Patterns of Sun Pharma Advanced Resea

Share has hit Six Months high on 27-Jan-20.
Stock has jumped by more than 15% in last One Month from its lowest level of 155.2 dt 02-Jan-20.
Stock has jumped by more than 25% in last three Month from its lowest level of 126.4 dt 29-Oct-19.
Stock has jumped by more than 50% in last Six Month from its lowest level of 113.4 dt 09-Oct-19.
Share is making strong moves on recent weekly chart. Such movements may give an opportunity for short term trading.
Stock - Sun Pharma Advanced Resea has made higher level with higher volume market in uptrend
Bullish piercing Candlestick pattern was formed by Sun Pharma Advanced Resea on 23/01/2020
More Chart Patterns Sun Pharma Advanced Resea ...
You can now customize Equity with technical , SMA , Fin Data, chart patterns in one Page. Click here to view guide

Share Price History of Sun Pharma Advanced Resea

Date Open High Low Close Volume
27-Jan-20 184.65 201.25 183.60 198.25 2277 K
24-Jan-20 185.60 188.00 183.50 185.85 311 K
23-Jan-20 181.20 186.55 181.20 184.70 385 K
22-Jan-20 186.70 188.90 181.35 182.50 479 K
21-Jan-20 191.85 194.00 184.00 186.15 475 K
20-Jan-20 189.50 197.00 187.50 193.30 1322 K
17-Jan-20 190.65 191.70 187.50 188.65 515 K
16-Jan-20 190.00 193.50 188.25 190.65 455 K
15-Jan-20 191.10 191.60 187.00 189.05 543 K
14-Jan-20 191.00 194.50 188.40 192.40 1480 K
About Sun Pharma Advanced Research Company Limited
Sun Pharma Advanced Research Company Limited engages in the research and development of pharmaceutical products in India and internationally. The company develops new chemical entities or reformulated products based on its proprietary novel drug delivery systems. Its core therapeutic areas of interest include oncology, inflammation, and neurodegenerative diseases, as well as abuse deterrent formulations. The company offers Levetiracetam ER for epilepsy; and Xelpros eye drops for Glaucoma. It is also developing Taclantis for the treatment of cancer; salmeterol-fluticasone dry powder inhaler for use in asthma and COPD; Baclofen GRS for spasticity; Brimonidine OD for glaucoma and ocular hypertension; and SDN-037 steroid eye drops used for the treatment of pain and inflammation following ocular surgery, and other inflammatory ocular conditions. In addition, the company engages in the development of SCO-088, a Bcr?Abl kinase inhibitor for treatment resistant chronic myelogenous leukaemia (CML); SDN-021, an abuse deterrent formulation; and SCD-044, a S1P receptor-1 agonist, which uses lymphocyte trafficking to treat auto-immune disorders. Further, it develops SCC?138 for Parkinson's disease; SDN?118, a formulation for treating depression; SDD-098 to treat acne; and SDE-124, a sub cutaneous injection of GLP-1 receptor agonists, as well as SCO-125 to treat CML. Sun Pharma Advanced Research Company Limited has a collaboration agreement with Bioprojet to develop S1P receptor 1 agonist for autoimmune disorders; and HitGen to identify small molecule leads for targets of interest. The company was incorporated in 2006 and is based in Mumbai, India. Sun Pharma Advanced Research Company Limited is a subsidiary of Shanghvi Finance Pvt. Ltd.
About Strength

Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is currently calculated around around 5 to 6 PM. This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback

We are working on fundamental strength also. Please share your views to help shape up the requirement.

( Intraday Analysis is on 15 Mins Delayed Data. All Other analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)


All Rights Reserved By Mintnovate Market Research Pvt Ltd.